Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Shares Outstanding: 266.26M for Oct. 25, 2023
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 25, 2023 | 266.26M |
September 30, 2023 | 265.84M |
July 25, 2023 | 248.94M |
June 30, 2023 | 248.71M |
May 09, 2023 | 234.12M |
May 03, 2023 | 204.22M |
April 21, 2023 | 226.07M |
April 10, 2023 | 226.07M |
March 31, 2023 | 226.07M |
February 21, 2023 | 226.05M |
December 31, 2022 | 226.05M |
October 31, 2022 | 220.75M |
September 30, 2022 | 220.75M |
July 25, 2022 | 220.71M |
June 30, 2022 | 220.64M |
May 02, 2022 | 220.54M |
April 08, 2022 | 220.54M |
March 31, 2022 | 220.54M |
February 16, 2022 | 220.53M |
December 31, 2021 | 220.36M |
December 06, 2021 | 220.11M |
October 26, 2021 | 202.62M |
September 30, 2021 | 202.44M |
August 09, 2021 | 202.40M |
July 27, 2021 | 201.63M |
Date | Value |
---|---|
June 30, 2021 | 200.26M |
April 30, 2021 | 199.94M |
April 12, 2021 | 199.94M |
March 31, 2021 | 199.94M |
February 18, 2021 | 199.73M |
December 31, 2020 | 195.00M |
December 17, 2020 | 194.71M |
October 30, 2020 | 187.53M |
October 09, 2020 | 187.28M |
September 30, 2020 | 174.58M |
July 30, 2020 | 174.54M |
June 30, 2020 | 174.54M |
April 30, 2020 | 174.41M |
April 13, 2020 | 174.40M |
March 31, 2020 | 174.26M |
March 04, 2020 | 174.32M |
January 27, 2020 | 174.66M |
December 31, 2019 | 150.14M |
October 31, 2019 | 149.70M |
September 30, 2019 | 149.69M |
July 31, 2019 | 149.88M |
June 30, 2019 | 149.88M |
April 30, 2019 | 149.53M |
April 23, 2019 | 149.53M |
March 31, 2019 | 149.42M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
149.69M
Minimum
Sep 30 2019
266.26M
Maximum
Oct 25 2023
202.60M
Average
202.40M
Median
Aug 09 2021
Shares Outstanding Benchmarks
AbbVie Inc | 1.766B |
Pfizer Inc | 5.667B |
Johnson & Johnson | 2.407B |
Merck & Co Inc | 2.533B |
Cerevel Therapeutics Holdings Inc | 182.19M |